Photodynamic therapy: a treatment option in choroidal neovascularisation secondary to punctate inner choroidopathy.
作者信息
Chatterjee S, Gibson J M
出版信息
Br J Ophthalmol. 2003 Jul;87(7):925-7. doi: 10.1136/bjo.87.7.925-a.
Abstract
摘要
相似文献
1
Photodynamic therapy: a treatment option in choroidal neovascularisation secondary to punctate inner choroidopathy.光动力疗法：点状内层脉络膜病变继发脉络膜新生血管形成的一种治疗选择。
Br J Ophthalmol. 2003 Jul;87(7):925-7. doi: 10.1136/bjo.87.7.925-a.
2
Management of inflammatory choroidal neovascularization (CNV) secondary to punctate inner choroidopathy in a young female of childbearing age with intra-vitreal ranibizumab and half-fluence photodynamic therapy (PDT) - a holistic approach.采用玻璃体内注射雷珠单抗和半剂量光动力疗法（PDT）对一名育龄期年轻女性继发于点状内层脉络膜病变的炎症性脉络膜新生血管（CNV）进行治疗——一种整体治疗方法。
Semin Ophthalmol. 2012 Jan-Mar;27(1-2):29-32. doi: 10.3109/08820538.2011.622334.
3
Photodynamic therapy combined with systemic corticosteroids for choroidal neovascularisation secondary to punctate inner choroidopathy.光动力疗法联合全身糖皮质激素治疗点状内层脉络膜病变继发脉络膜新生血管
Eye (Lond). 2008 Apr;22(4):528-33. doi: 10.1038/sj.eye.6702688. Epub 2007 Jan 19.
4
Positive response to intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to punctate inner choroidopathy.眼内雷珠单抗治疗特发性脉络膜毛细血管炎继发黄斑区脉络膜新生血管的疗效观察。
Retina. 2010 Oct;30(9):1400-4. doi: 10.1097/IAE.0b013e3181d374dc.
5
[Intravitreal ranibizumab (Lucentis®) in the treatment of choroidal neovascular membrane secondary to punctate inner choroidopathy].玻璃体内注射雷珠单抗（Lucentis®）治疗点状内层脉络膜病变继发的脉络膜新生血管膜
Arch Soc Esp Oftalmol. 2010 Apr;85(4):149-52.
6
Resolution of choroidal neovascularization secondary to punctate inner choroidopathy (PIC) with intravitreal anti-VEGF agents: a case series.玻璃体内抗血管内皮生长因子（VEGF）药物治疗点状内层脉络膜病变（PIC）继发脉络膜新生血管的疗效：病例系列报道
Semin Ophthalmol. 2011 Jan;26(1):1-3. doi: 10.3109/08820538.2010.541322.
7
Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression.光动力疗法治疗对免疫抑制无反应的炎症性脉络膜新生血管形成
Br J Ophthalmol. 2005 Feb;89(2):147-50. doi: 10.1136/bjo.2004.046623.
8
Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective series.光动力疗法联合玻璃体内注射曲安奈德治疗点状内层脉络膜病变继发或特发性脉络膜新生血管：前瞻性系列研究的一年结果
Retina. 2008 Jan;28(1):71-80. doi: 10.1097/IAE.0b013e31815e9339.
9
[Choroidal neovascularisation in a patient with punctate inner choroidopathy (PIC)].
Klin Monbl Augenheilkd. 2011 Oct;228(10):915-7. doi: 10.1055/s-0029-1245792. Epub 2011 Mar 24.
10
Unilateral Punctate inner choroidopathy with choroidal neovascular membrane in a young male.一名年轻男性患有伴有脉络膜新生血管膜的单侧点状内层脉络膜病变。
Indian J Ophthalmol. 2014 Sep;62(9):949-50. doi: 10.4103/0301-4738.143939.
引用本文的文献
1
[White dot syndromes : Principles, diagnostics, and treatment].[白点综合征：原理、诊断与治疗]
Ophthalmologe. 2019 Dec;116(12):1235-1256. doi: 10.1007/s00347-019-01012-5.
2
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy.玻璃体内抗血管内皮生长因子治疗点状内层脉络膜病变继发的脉络膜新生血管。
Int Ophthalmol. 2018 Jun;38(3):923-931. doi: 10.1007/s10792-017-0536-0. Epub 2017 Apr 19.
3
A 39-year-old woman with unilateral metamorphosias.一名患有单侧视物变形症的39岁女性。
Digit J Ophthalmol. 2011;17(4):74-8. doi: 10.5693/djo.03.2011.11.001. Epub 2011 Nov 20.
4
Choroidal neovascularization due to punctate inner choroidopathy: long-term follow-up and review of literature.点状内层脉络膜病变所致脉络膜新生血管形成：长期随访及文献复习
Clin Ophthalmol. 2010 Aug 9;4:871-6. doi: 10.2147/opth.s10394.
5
[White dot syndrome].[白点综合征]
Ophthalmologe. 2008 Jan;105(1):91-108; quiz 109. doi: 10.1007/s00347-007-1687-6.
6
Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression.光动力疗法治疗对免疫抑制无反应的炎症性脉络膜新生血管形成
Br J Ophthalmol. 2005 Feb;89(2):147-50. doi: 10.1136/bjo.2004.046623.
本文引用的文献
1
Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks.维替泊芬光动力疗法治疗血管样条纹患者脉络膜新生血管化
Am J Ophthalmol. 2002 Sep;134(3):360-6. doi: 10.1016/s0002-9394(02)01626-4.
2
Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series.眼部组织胞浆菌病综合征中使用维替泊芬对黄斑下脉络膜新生血管进行光动力疗法：一项非对照前瞻性病例系列研究的一年结果
Ophthalmology. 2002 Aug;109(8):1499-505. doi: 10.1016/s0161-6420(02)01103-x.
3
Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin.
Am J Ophthalmol. 2002 Jul;134(1):62-8. doi: 10.1016/s0002-9394(02)01452-6.
4
Photodynamic therapy for choroidal neovascularization in fundus flavimaculatus.光动力疗法治疗黄斑营养不良性脉络膜新生血管
Retina. 2002 Feb;22(1):111-3. doi: 10.1097/00006982-200202000-00022.
5
Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.使用维替泊芬（维速达尔）进行光动力疗法治疗年龄相关性黄斑变性及其他原因引起的脉络膜新生血管的指南。
Retina. 2002 Feb;22(1):6-18. doi: 10.1097/00006982-200202000-00003.
6
Photodynamic therapy with verteporfin in mallatia leventinese.维替泊芬光动力疗法治疗莱文特氏脉络膜炎。
Ophthalmology. 2002 Feb;109(2):296-301. doi: 10.1016/s0161-6420(01)00927-7.
7
Photodynamic therapy for choroidal neovascularization associated with choroidal osteoma.光动力疗法治疗与脉络膜骨瘤相关的脉络膜新生血管
Retina. 2001;21(6):660-1. doi: 10.1097/00006982-200112000-00016.
8
Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.2A型特发性黄斑旁视网膜毛细血管扩张症视网膜下新生血管膜的光动力疗法
Am J Ophthalmol. 2002 Jan;133(1):149-51. doi: 10.1016/s0002-9394(01)01205-3.
9
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.维替泊芬光动力疗法治疗病理性近视性黄斑下脉络膜新生血管。一项随机临床试验的1年结果——VIP报告第1号
Ophthalmology. 2001 May;108(5):841-52. doi: 10.1016/s0161-6420(01)00544-9.
Zotero 插件